首页> 美国卫生研究院文献>Diabetes >In Vivo Adipogenesis in Rats Measured by Cell Kinetics in Adipocytes and Plastic-Adherent Stroma-Vascular Cells in Response to High-Fat Diet and Thiazolidinedione
【2h】

In Vivo Adipogenesis in Rats Measured by Cell Kinetics in Adipocytes and Plastic-Adherent Stroma-Vascular Cells in Response to High-Fat Diet and Thiazolidinedione

机译:通过对高脂饮食和噻唑烷二酮的脂肪细胞和可塑性粘附的基质血管细胞的细胞动力学测定的大鼠体内脂肪形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Impairment of adipogenesis contributes to the development of obesity-related insulin resistance. The current in vitro approaches for its assessment represent crude estimates of the adipogenic potential because of the disruption of the in vivo microenvironment. A novel assessment of in vivo adipogenesis using the incorporation of the stable isotope deuterium (2H) into the DNA of isolated adipocytes and stroma-vascular fraction from adipose tissue has been developed. In the current study, we have refined this technique by purifying the adipocytes via a negative immune selection and sorting the plastic adherent stroma-vascular (aSV) subfraction (using 3 h culture) that contains mostly adipocyte progenitor cells and ∼10% of small adipocytes. Using a 3-week 8% 2H2O ingestion with a high-fat diet (HFD) or HFD plus pioglitazone (HFD-P), we demonstrate that the fractions of new aSV cells (faSV) and immunopurified adipocytes (fAD) (the ratio of their 2H-enrichment of DNA to the maximal 2H-enrichment of DNA of bone marrow reference cells) recapitulate the known hyperplastic mechanism of weight gain with pioglitazone treatment. We conclude that faSV and fAD are reliable indices of in vivo adipogenesis. The proposed method represents a valuable tool for studying the effect of interventions (drugs, diets, and exercise) on in vivo adipogenesis.
机译:脂肪形成的障碍有助于肥胖相关的胰岛素抵抗的发展。由于体内微环境的破坏,目前评估其的体外方法代表了对成脂潜能的粗略估计。通过将稳定的同位素氘( 2 H)掺入分离的脂肪细胞的DNA和来自脂肪组织的基质-血管部分中,开发了一种体内脂肪形成的新方法。在当前的研究中,我们通过负免疫选择纯化脂肪细胞并对塑料粘附性基质-血管(aSV)亚组分(使用3 h培养物)进行分选来完善该技术,该组分主要包含脂肪细胞祖细胞和约10%的小脂肪细胞。使用高脂饮食(HFD)或HFD加吡格列酮(HFD-P)进行的为期3周的8% 2 H2O摄入,我们证明了新aSV细胞(faSV)的成分和经过免疫纯化脂肪细胞(fAD)(其 2 H富集的DNA与最大的 2 H富集的骨髓参考细胞的DNA的比率)概括了已知的增生机制吡格列酮治疗可使体重增加。我们得出结论,faSV和fAD是体内脂肪形成的可靠指标。所提出的方法是研究干预措施(药物,饮食和运动)对体内脂肪形成的影响的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号